{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:27:21Z","timestamp":1792373241825,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.abb.2025.110594","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:20:40Z","timestamp":1755235240000},"page":"110594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Molecular and structural characterization of ureido-benzenesulfonamides as dual inhibitors of aldose reductase and cholinesterases"],"prefix":"10.1016","volume":"773","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebih","family":"Lolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Esra","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6n\u00fcl","family":"Yapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4506-5265","authenticated-orcid":false,"given":"Suleyman","family":"Akocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.abb.2025.110594_bib1","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.3390\/molecules26196057","article-title":"Drugs that changed society: history and current status of the early antibiotics: Salvarsan, sulfonamides, and \u03b2-Lactams","volume":"26","author":"Christensen","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophysical Rev."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/0929867329666220729151500","article-title":"Sulfonamide moiety as \u201cMolecular Chimera\u201d in the design of new drugs","volume":"30","author":"Giulia","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"22","key":"10.1016\/j.abb.2025.110594_bib4","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"T Supuran","year":"2021","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.abb.2025.110594_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14728222.2023.2263914","article-title":"An overview of novel antimicrobial carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.abb.2025.110594_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129479","article-title":"Potent and selective carbonic anhydrase inhibition activities of pyrazolones bearing benzenesulfonamides","volume":"95","author":"Akocak","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2185762","article-title":"Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties","volume":"38","author":"Tekeli","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: design, synthesis, and in vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.abb.2025.110594_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.abb.2025.110594_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107409","article-title":"Sulfonamides as anticancer agents: a brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer","volume":"147","author":"Elsayad","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113837","article-title":"Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation","volume":"226","author":"Wan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.abb.2025.110594_bib13","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/molecules27051604","article-title":"An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents","volume":"27","author":"Rubab","year":"2022","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.abb.2025.110594_bib14","doi-asserted-by":"crossref","first-page":"14247","DOI":"10.1021\/acsomega.3c01273","article-title":"Novel sulfonamide\u2013triazine hybrid derivatives: docking, synthesis, and biological evaluation as anticancer agents","volume":"8","author":"Alelaimat","year":"2023","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.abb.2025.110594_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/14756360600810340","article-title":"Antibacterial, antifungal and cytotoxic properties of novel N-substituted sulfonamides from 4-hydroxycoumarin","volume":"21","author":"Chohan","year":"2006","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib16","article-title":"New antibacterial, antifungal and antioxidant agents bearing sulfonamide","volume":"10","author":"Ochu","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/138955713804484749","article-title":"Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents","volume":"13","author":"Shoaib Ahmad Shah","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"18","key":"10.1016\/j.abb.2025.110594_bib18","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1080\/07391102.2023.2252083","article-title":"Acetylsalicylic acid-sulfa drugs conjugates as potential urease inhibitors and anti-inflammatory agents: bio-oriented drug synthesis, molecular docking, and dynamics simulation studies","volume":"42","author":"Ahmad","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/molecules28010051","article-title":"Sulfonamides with heterocyclic periphery as antiviral agents","volume":"28","author":"Moskalik","year":"2023","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.abb.2025.110594_bib20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2174\/1385272824999200515094100","article-title":"Sulfonamides: antiviral strategy for neglected tropical disease virus","volume":"24","author":"Rudra Narayan","year":"2020","journal-title":"Curr. Org. Chem."},{"issue":"6","key":"10.1016\/j.abb.2025.110594_bib21","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.abb.2025.110594_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.abb.2025.110594_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI insight"},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","article-title":"Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion","volume":"41","author":"Sarnella","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.abb.2025.110594_bib25","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2025.110594_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biom12040485","article-title":"In search of differential inhibitors of aldose reductase","volume":"12","author":"Balestri","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.abb.2025.110594_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/biomedicines12040747","article-title":"Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: a comprehensive review","volume":"12","author":"D\u0103nil\u0103","year":"2024","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.abb.2025.110594_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12272-021-01343-5","article-title":"Aldose reductase: a cause and a potential target for the treatment of diabetic complications","volume":"44","author":"Thakur","year":"2021","journal-title":"Arch. Pharmacal Res."},{"issue":"10","key":"10.1016\/j.abb.2025.110594_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.abb.2025.110594_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.abb.2025.110594_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135761","article-title":"Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities","volume":"280","author":"Ahmad","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1389557515666150909143737","article-title":"Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases","volume":"16","author":"Singh Grewal","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.abb.2025.110594_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ptr.5000","article-title":"Aldose reductase inhibitors of plant origin","volume":"28","author":"Veeresham","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.abb.2025.110594_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139207","article-title":"Selectivity challenges for aldose reductase inhibitors: a review on comparative SAR and interaction studies","volume":"1318","author":"Kumari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.abb.2025.110594_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110856","article-title":"Aldose reductase is a potential therapeutic target for neurodegeneration","volume":"389","author":"Rao","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib37","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"issue":"8","key":"10.1016\/j.abb.2025.110594_bib38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"9","key":"10.1016\/j.abb.2025.110594_bib39","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0223-5234(98)80033-0","article-title":"Carbonic anhydrase inhibitors - part 49: synthesis of substituted ureido and thioureido derivatives of aromatic\/heterocyclic sulfonamides with increased affinities for isozyme I","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.abb.2025.110594_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/14756369909030328","article-title":"Carbonic anhydrase inhibitors. Arylsulfonylureido-and Arylureido-Substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I","volume":"14","author":"Scozzafava","year":"1999","journal-title":"J. Enzym. Inhib."},{"issue":"20","key":"10.1016\/j.abb.2025.110594_bib42","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.bmcl.2008.09.030","article-title":"Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic\/heterocyclic sulfonamides\u2014in vitro and in vivo studies","volume":"18","author":"Krungkrai","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"null","key":"10.1016\/j.abb.2025.110594_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.abb.2025.110594_bib44","unstructured":"Aminobenzenesulfonamide Derivatives as colour-developers for Thermosensitive Recording Materials. Patent (EP 0 693386 A1)."},{"issue":"11","key":"10.1016\/j.abb.2025.110594_bib45","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/jm00161a033","article-title":"Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids","volume":"29","author":"Cerelli","year":"1986","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.abb.2025.110594_bib47","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.bmc.2017.03.056","article-title":"N-(Aroyl)-N-(arylmethyloxy)-\u03b1-alanines: selective inhibitors of aldose reductase","volume":"25","author":"Nencetti","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.abb.2025.110594_bib48","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1021\/jm101008m","article-title":"A diverse series of substituted benzenesulfonamides as Aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity","volume":"53","author":"Alexiou","year":"2010","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2025.110594_bib49","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11030-022-10526-1","article-title":"Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors","volume":"27","author":"Demir","year":"2023","journal-title":"Mol. Divers."},{"issue":"19","key":"10.1016\/j.abb.2025.110594_bib50","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1080\/07391102.2021.1916599","article-title":"Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","volume":"40","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.abb.2025.110594_bib51","doi-asserted-by":"crossref","DOI":"10.25135\/acg.bmcr.22.20.07.1706","article-title":"Synthesis and biological evaluation of 1, 3, 5-triazine-substituted ureido benzenesulfonamides as antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"3","author":"Lolak","year":"2020","journal-title":"Bioorg. Med. Chem. Rep."},{"issue":"4","key":"10.1016\/j.abb.2025.110594_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11030-022-10527-0","article-title":"Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors","volume":"27","author":"Lolak","year":"2023","journal-title":"Mol. Divers."},{"issue":"23","key":"10.1016\/j.abb.2025.110594_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400485","article-title":"Bis-Ureido-Substituted benzenesulfonamides: evaluation of their antibacterial, anticholinesterase, and cytotoxicity properties","volume":"9","author":"Tekeli","year":"2024","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.abb.2025.110594_bib55","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, Octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.abb.2025.110594_bib56","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1021\/acs.jmedchem.1c01548","article-title":"New drug modalities in medicinal chemistry, pharmacology, and translational science: joint virtual special issue by journal of medicinal chemistry, ACS medicinal chemistry letters, and ACS pharmacology & translational science","volume":"64","author":"M\u00fcller","year":"2021","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.abb.2025.110594_bib57","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/acschemneuro.0c00328","article-title":"Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration","volume":"11","author":"Landgraf","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"22","key":"10.1016\/j.abb.2025.110594_bib58","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.febslet.2013.09.031","article-title":"Inhibitor selectivity between aldo\u2013keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111)","volume":"587","author":"Zhang","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2025.110594_bib59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijbiomac.2022.05.009","article-title":"Crystal structure of human acetylcholinesterase in complex with tacrine: implications for drug discovery","volume":"210","author":"Dileep","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.abb.2025.110594_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-alzheimer's drugs targeting acetyl- and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.abb.2025.110594_bib61","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/ci700271z","article-title":"Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB\/SA scoring","volume":"47","author":"Barreiro","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.abb.2025.110594_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110161","article-title":"Aldose reductase with quinolone antibiotics interaction: in vitro and in silico approach of its relationship with diabetic complications","volume":"761","author":"T\u00fcrke\u015f","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"48","key":"10.1016\/j.abb.2025.110594_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204050","article-title":"In vitro inhibitory activity and molecular docking study of selected natural phenolic compounds as AR and SDH inhibitors","volume":"7","author":"T\u00fcrke\u015f","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.abb.2025.110594_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135077","article-title":"A novel series of thiosemicarbazone hybrid scaffolds: design, synthesis, DFT studies, metabolic enzyme inhibition properties, and molecular docking calculations","volume":"1280","author":"Yakan","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.abb.2025.110594_bib65","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ddr.21667","article-title":"Naphthoquinones, benzoquinones, and anthraquinones: molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases","volume":"81","author":"Demir","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.abb.2025.110594_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.abb.2025.110594_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200554","article-title":"Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif","volume":"356","author":"Demir","year":"2023","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"issue":"7","key":"10.1016\/j.abb.2025.110594_bib68","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.abb.2025.110594_bib69","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.abb.2025.110594_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2991","article-title":"-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors","volume":"35","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.abb.2025.110594_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: Rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.abb.2025.110594_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.abb.2025.110594_bib73","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan Assay Interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib74","doi-asserted-by":"crossref","first-page":"108788","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2025.110594_bib75","doi-asserted-by":"crossref","first-page":"108861","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: Rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg. Chem."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125003078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125003078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:51:24Z","timestamp":1760590284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125003078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":75,"alternative-id":["S0003986125003078"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110594","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and structural characterization of ureido-benzenesulfonamides as dual inhibitors of aldose reductase and cholinesterases","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110594"}}